Christopher John Morl, Chief Business Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 26,212 shares at $60.02 ($1.6M) on 2020-01-07, disclosed to the SEC on 2020-01-09.
Open-market sale of $1.6M DCPH by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.02 | 1,650 | $99K | 6.3% |
| 2 | $60.12 | 12,281 | $738K | 46.9% |
| 3 | $60.12 | 12,281 | $738K | 46.9% |
| Total | $60.11 avg | 26,212 | $1.6M | 100% |
| Filing → |
| DCPH | SELL | 2019-12-13 | $902K | — | Filing → |
| DCPH | SELL | 2019-12-11 | $827K | — | Filing → |
| DCPH | SELL | 2019-12-05 | $752K | — | Filing → |